Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults - Wikidata - wikimedia - TriplyDB

Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults

Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults

http://www.wikidata.org/entity/Q24200813

about

The biology of graft-versus-host disease: experimental systems instructing clinical practice.Population pharmacokinetic/dynamic model of lymphosuppression after fludarabine administration.Graft-versus-host disease prophylaxis after transplantation: a network meta-analysis.Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Immunosuppressants in Allogeneic Hematopoietic Cell Transplantation: Part II.Prophylactic and therapeutic treatment of graft-versus-host disease in Japan.Immune reconstitution and outcomes after conditioning with anti-thymocyte-globulin in unrelated cord blood transplantation; the good, the bad, and the ugly.Successful desensitization of a patient with aplastic anemia to antithymocyte globulin.Rabbit antithymocyte globulin induces rapid expansion of effector memory CD8 T cells without accelerating acute graft versus host disease.Horse versus rabbit antithymocyte globulin in immunosuppressive therapy of treatment-naïve aplastic anemia: a systematic review and meta-analysis.Population pharmacokinetic modeling of Thymoglobulin(®) in children receiving allogeneic-hematopoietic cell transplantation: towards improved survival through individualized dosing.The Role of Anti-Thymocyte Globulin or Alemtuzumab-Based Serotherapy in the Prophylaxis and Management of Graft-Versus-Host Disease.

P2860

Q33917175-01FD979F-859E-479D-B9D3-86C4E978D34E Q34807259-53CA6CEF-0F2E-4C5B-AE81-0F54A91B4768 Q35499395-D691F817-89D2-40A1-BB46-EDA571FFCFD9 Q35892249-3C5BEFE4-17D5-41C5-8783-F7BD9E8DE485 Q36777485-A70534BE-9352-4DE9-8CBB-19D772A5EF03 Q38416371-D97960F0-A884-40A2-8E4C-D2A660C8D6E0 Q38728525-237A34C6-A878-4DAF-A159-D62D43827613 Q39359621-123CB095-1BB3-4E5C-B66D-8DD3639E4067 Q41965022-04D860B5-4659-4139-87D1-E505F7F05104 Q47720099-B3C8F843-3D32-47CA-8663-BB7E2523A6D1 Q51000653-66749154-A9DB-4BD5-BED4-C8B8C8D9A4EB Q54308886-50B8D9D3-C499-4A30-B300-52828AD30C56

P2860

Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults

http://www.wikidata.org/entity/Q24200813

description

2012 nî lūn-bûn

@nan

2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Polyclonal anti-thymocyte glob ...... rrow transplantation in adults

@ast

Polyclonal anti-thymocyte glob ...... rrow transplantation in adults

@en

Polyclonal anti-thymocyte glob ...... rrow transplantation in adults

@en-gb

Polyclonal anti-thymocyte glob ...... rrow transplantation in adults

@nl

type

label

Polyclonal anti-thymocyte glob ...... rrow transplantation in adults

@ast

Polyclonal anti-thymocyte glob ...... rrow transplantation in adults

@en

Polyclonal anti-thymocyte glob ...... rrow transplantation in adults

@en-gb

Polyclonal anti-thymocyte glob ...... rrow transplantation in adults

@nl

prefLabel

Polyclonal anti-thymocyte glob ...... rrow transplantation in adults

@ast

Polyclonal anti-thymocyte glob ...... rrow transplantation in adults

@en

Polyclonal anti-thymocyte glob ...... rrow transplantation in adults

@en-gb

Polyclonal anti-thymocyte glob ...... rrow transplantation in adults

@nl

P1433

Q24200813-12C4D434-8ECB-4260-95F4-E971DE6F3577

P1476

Q24200813-8191FC22-300A-4C7D-BF00-27CBF125E480

P2093

Q24200813-47F3DC3E-AA31-4D58-97B8-C72D1760A53F

Q24200813-79284987-9603-454B-A63E-C34CB2DCBE9D

Q24200813-BB787908-52EE-4970-867D-CCC426D783BC

P2860

Q24200813-02E99BBB-0E21-4368-B16D-12D1B90EFD79

Q24200813-0773AA74-C2A4-4DFE-A288-AEEF43F830CA

Q24200813-17D4942F-C4D0-4792-9EDC-37171C82637D

Q24200813-21293CED-8C8B-4E12-AA83-A8B9D089AFD7

Q24200813-2928B4C9-D421-491A-BE58-95EACA45851C

Q24200813-2A5B5712-028A-46FF-875D-0C8E6D5032C1

Q24200813-2CB930CA-319C-4626-91A8-132DBEBAC6CB

Q24200813-3E81FD30-9087-4F6F-83BF-4DBE79BE818C

Q24200813-57392BA2-D7C9-4EC2-909D-22AE947C2F4D

Q24200813-602504C9-4D9C-4FC3-89F0-01AFC5A701C4

P31

Q24200813-548fae82-d636-4b76-ad96-8911a55c8244

Q24200813-68779895-DF6E-482C-96D1-8E08269C1055

P356

Q24200813-6E9B372C-92A4-4FAB-96E5-D9D99885124D

P50

Q24200813-1E40CC4E-BF00-49D0-ACC8-279965B28F87

Q24200813-264E1630-85F5-4417-9BF7-4AE788BEC915

Q24200813-5D33A7E7-C9FF-4749-BEED-E571B7036C36

Q24200813-84832056-D029-4A58-BC43-387CF5CA3C47

Q24200813-FDACCB9D-5CCD-4768-87AD-0F2F259F2F99

P577

Q24200813-735DA300-F815-43C5-BAC3-9E3E74520360

P5875

Q24200813-95CDDE8E-90D8-4670-A8B9-BC863D926D5C

P698

Q24200813-1916BFC6-2CCD-4770-A60F-FC62BCB8E5C1

P921

Q24200813-DDF4621F-9775-4FD6-A711-59CD5B3578EF

P356

14651858.CD009159.PUB2

P1433

Cochrane Database of Systematic Reviews

P1476

Polyclonal anti-thymocyte glob ...... rrow transplantation in adults

@en

P2093

Christof Scheid

http://www.w3.org/2001/XMLSchema#string

Hans Fischmann

http://www.w3.org/2001/XMLSchema#string

Jens M Chemnitz

http://www.w3.org/2001/XMLSchema#string

P2860

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

Practical methods for incorporating summary time-to-event data into meta-analysis

A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host disease

Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium

Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).

Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre, randomised phase II-III trial.

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation.

Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond.

P31

scholarly article

P356

10.1002/14651858.CD009159.PUB2

http://www.w3.org/2001/XMLSchema#string

P50

Alexander Shimabukuro-Vornhagen

Michael von Bergwelt-Baildon

Sebastian Theurich

P577

2012-09-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230842962

http://www.w3.org/2001/XMLSchema#string

P698

22972135

http://www.w3.org/2001/XMLSchema#string

P921